Biostage is an emerging leader in regenerative medicine, patient-specific stem cell therapy, and tissue engineering. Its robust pipeline of Cellspan implants, based on its proprietary Cellframe technology, is being developed to address unmet medical needs in esophageal, bronchial and tracheal cancers, trauma and congenital abnormalities where current standards of care are suboptimal or lacking altogether.